$1.33
+0.12 (+9.92%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,094.0% upside
Low Target
$17.82
Average Target
$29.18
High Target
$40.31
Current Price
$1.33
Current
$1.33
$1.33
Target
$29.18
$29.18
$17.82
$29.18 avg
$40.31
Scenario Analysis
Bear Case
$17.82
1,239.8%
Low target
Base Case
$29.18
+2,094.0%
Avg target
Bull Case
$40.31
+2,930.8%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$3.79
-64.9% from high
52-Week Low
$0.82
+62.2% from low
Target vs 52W High
$29.18
+669.9% vs high
Next Earnings Report
Nov 9, 2026
1d
tomorrow
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |